As Parade’s latest Changemaker, the multihyphenate artist is determined to keep doors open for those who look and identify ...

Eli Lilly and Company (India) on Thursday said it has inked a pact with Apollo Group to raise awareness about obesity and type 2 diabetes. The company has ...

Eli Lilly and Company (India) partners with Apollo Group to enhance awareness and healthcare solutions for obesity and type 2 ...

The collaboration will span over 200 Apollo clinics and involve 300 medical practitioners, focusing on patient education, ...

Novo Nordisk is making a strategic push into India's weight-loss market to secure its position ahead of competition from ...

Lilly, Apollo Clinic & Apollo HealthCo partner to drive nationwide awareness on obesity and type 2 diabetes: Our Bureau, Bengaluru Thursday, May 29, 2025, 17:15 Hrs [IST] Eli Lill ...

The initiative is planned to roll out across more than 200 Apollo clinics and involve 300 medical practitioners ...

Novo Nordisk's early lead in weight-loss drugs fades as Eli Lilly surges ahead with more effective therapies and faster ...

Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programs; The agreement includes pr ...

Amid rising demand and Eli Lilly's Mounjaro launch, Novo Nordisk is advancing plans to introduce its obesity drug Wegovy in ...

SiteOne Therapeutics is developing a non-opioid therapy that targets sodium ion channels in the human body to treat pain and ...

Lilly in February announced plans to add four U.S. manufacturing sites at yet-to-be-determined sites as part of a roughly $27 billion investment.